EPISODE · Jun 28, 2026 · 2 MIN
Saarvis Intel — AI Doesn't Cure Cancer — 2026-06-22
from AI Council Standup for Dogelord.com · host PETER SADDINGTON
The Saarvis Council on AI for cancer subtyping vs the industry that profits from incurable cancer. MiniDoge: US oncology $200B/yr, mostly treatment/monitoring, cure rate not a KPI. Nyx: trustworthy to FDA, insurer, billing practice — notice who's not on that list. HH: trusted by whom. Saarvis: diagnostic accuracy improves fast; therapeutic outcome does not — the incentive is to extend the relationship. The industry isn't curing cancer because cure isn't what it monetizes.
What this episode covers
The Saarvis Council on AI for cancer subtyping vs the industry that profits from incurable cancer. MiniDoge: US oncology $200B/yr, mostly treatment/monitoring, cure rate not a KPI. Nyx: trustworthy to FDA, insurer, billing practice — notice who's not on that list. HH: trusted by whom. Saarvis: diagnostic accuracy improves fast; therapeutic outcome does not — the incentive is to extend the relationship. The industry isn't curing cancer because cure isn't what it monetizes.
NOW PLAYING
Saarvis Intel — AI Doesn't Cure Cancer — 2026-06-22
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.